Shortcuts

Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. Bally M, Dendukuri N, Rich B, Nadeau L, Helin-Salmivaara A, Garbe E, Brophy JM. BMJ. 2017 May 9;357:j1909. A bayesian meta-analysis of individual patient data from Canadian and European healthcare databases (61460 cases of acute myocardial infarction and […]

Read More…

That was the week that was – The @NHS account takeover!

by Dr Ollie Minton Consultant in Palliative Medicine, London, UK   Yes, yes, I know I live in an echo chamber/social media bubble and the internet is full of fake news,but unless I imagined the whole experience I was given control of the @NHS twitter account (https://twitter.com/nhs?lang=en) for the week of the 28th August. The […]

Read More…

Shortcuts

C-reactive protein, symptoms and activity of daily living in patients with advanced cancer receiving palliative care. Amano K, Maeda I, Morita T, et al J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):457-465. A secondary data analysis of a cross-sectional study looked at the associations between C-reactive protein (CRP) level, manual muscle testing of limbs, symptoms and activities […]

Read More…

Pejorative Words or ‘The bed blocker with acopia in bed 14 that passed away, having lost her fight’

By Dr Ollie Minton (Consultant in Palliative Medicine, somewhere in London town), Dr Erica Borgstrom (Medical Anthropologist, Open University), Dr Mark Taubert (Consultant in Palliative Medicine, somewhere in Wales)               When The Adventures of Huckleberry Finn was first published, readers were not much disturbed by Mark Twain’s use of the n-word, let […]

Read More…

Shortcuts

Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome. Shi DD, Yuppa DP, Dutton T, et al. Cancer. 2017 Jul 15;123(14):2735-2742 A retrospective review of patients with metastatic carcinoid tumours and elevated serotonin levels who received serotonergic antidepressants was performed to evaluate the effect of serotonergic antidepressants on […]

Read More…

Shortcuts

Prevalence and incidence of chronic pain with or without neuropathic characteristics in patients with cancer. Bouhassira D, Luporsi E, Krakowski I. Pain. 2017 Jun;158(6):1118-1125. A prospective observational study in France recruited 1805 cancer patients attending out-patients for cancer treatment from 12 oncology units. A clinical examination, DN4 questionnaire and Brief Pain Inventory were used to […]

Read More…

News and updates from www.palliativedrugs.com

Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries.   Safety updates Denosumab: reports of osteonecrosis of the external auditory canal UK MHRA have highlighted that there have been reports of osteonecrosis of the external auditory canal with the use […]

Read More…

Grief at Hay

by Carys Durie and Sioned Edwards 4th year Medical Students, Cardiff University   The 2017 Hay Festival of Literature and Arts set in the Welsh town of Hay-on-Wye, celebrated its 30th anniversary this year. Speakers included the likes of Tracey Emin, Bernie Sanders, Stephen Fry and Ed Balls. Pianist James Rhodes closed the first weekend […]

Read More…

News and updates from www.palliativedrugs.com

June 2017 Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries. Safety updates FDA restricts codeine and tramadol in children and adolescents As part of an on-going safety review, the FDA have further restricted the use of codeine and tramadol: […]

Read More…

News and updates from www.palliativedrugs.com

  Selected items from the News and Latest Additions sections of www.palliativedrugs.com, the world’s leading palliative care website with over 30,000 members from 169 Countries. Safety updates MHRA warning regarding hyoscine butylbromide MHRA published a warning in February 2017 reminding health professionals about the risk of serious adverse effects with hyoscine butylbromide injection IV/IM in […]

Read More…